|
 |
 |
Advertisement:
 Access Training You Need Now
With over 100 Live and On-Demand Online Training courses, and nearly 300 instructor led courses to choose from - CfPA’s Accredited courses can ensure you receive the skills and knowledge that will make a difference in your career. Register now for: Documentation Management Feb 22 NJ, Drug Product Stability Mar 8 NJ, or Effective FDA Submissions Feb 16 Online.
|
 Tablet coater operates with high efficiency
L.B. Bohle’s (Warminster, PA) Bohle Tablet Coater (BTC) was designed for efficient operation. The machine’s coating pan is longer and has a smaller diameter than coating pans in conventional units. This design results in a thin tablet bed that creates less static force than a typical coater bed. The BTC unit’s tablet bed is designed to eliminate slow-moving zones and reduces tablet twinning. The large bed surface area allows the machine to have more spray guns than common coaters.
Unlike traditional devices, the BTC brings air directly into the tablet bed from below. All airflow in the coater is through the bed in the direction of spray. Almost no air movement occurs in the spray zone, thus solution is not dried before it reaches the tablets. This design allows the BTC machine to operate with 96–98% efficiency, says Martin Hack, L.B. Bohle’s vice-president and general manager. |
|
|
 |
|
Abbott Laboratories (Abbott Park, IL) completed its acquisition of Solvay Pharmaceuticals (Belgium) for EUR $4.5 billion ($6.2 billion). Abbott expects the acquisition to add approximately $2.9 billion to the company’s 2010 total sales and about $500 million to Abbott's annual R&D investment.
Albemarle (Baton Rouge, LA), a provider of custom-manufacturing services, will partner with PharmaCore (High Point, NC) to provide manufacturing for customers needing high-volume capacity. PharmaCore provides organic synthesis.
Advertisement:
TOC Wet Chemical Analyzer Ensures Ultra-pure Water
Utilizing the exclusive Heated-UV-Persulfate oxidation method to provide rapid, efficient breakdown of hard-to-oxidize compounds, Shimadzu’s TOC-VW ensures ultra-pure water for pharmaceutical applications. Reduce analysis time with such features as random-access autosampler control and a high-sensitivity NDIR detector that eliminates false peaks. In addition, reduce the cost of ownership with low-cost consumables.
 Learn more. |
The US Food and Drug Administration approved the Amgen (Thousand Oaks, CA) and Centocor Ortho Biotech Products (Horsham PA) risk evaluation and mitigation strategy for erythropoiesis-stimulating agents (ESAs), which include Aranesp (darbepoetin alfa), EPOGEN (epoetin alfa) and PROCRIT (epoetin alfa). The drugs are used to treat patients with breast, non-small cell lung, head, neck, lymphoid, and cervical cancers.
AstraZeneca (London) and drug-development company Rigel Pharmaceuticals (South San Francisco, CA) will collaborate on the global development and marketing of fostamatinib disodium (R788), Rigel’s late-stage investigational product for rheumatoid arthritis (RA) and additional indications. Fostamatinib disodium is the furthest developed oral-spleen tyrosine kinase inhibitor being evaluated for RA. AstraZeneca will make an upfront payment to Rigel of $100 million. Rigel could receive with an additional $345 million from AstraZeneca if specified development, regulatory, and sales milestones are reached.
Advertisement:
Enwave Optronics, Inc. is the innovative leader in affordable Raman spectroscopy solutions. Enwave offer portable Raman instruments with best performances and prices in the industry. Raman microscopes and high sensitivity Raman instruments with the best performance-to-price ratios are also available.
 Click
here to read more. |
|
Materials-characterization expert Malvern Instruments (Malvern Worcestershire UK) opened a third center of excellence in Delhi, India. The new center, designed to serve customers in the north and northeast regions of India, houses laboratories equipped with Malvern systems and staffed by a full-time applications team that will provide demonstrations, training, applications and technical support, and sample analysis.
Novartis (Basel) gained exclusive rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent in Phase IIb development for the treatment of hepatitis C. Debio 025, the first in a new class of drugs called cyclophilin inhibitors, has been licensed from Debiopharm Group (Lausanne, Switzerland), an independent biopharmaceuticals company.
Advertisement:
analytica, March 23 – 26, 2010 in Munich, Germany
The world’s leading trade fair for Laboratory Technology, Analysis and Biotechnology. More than 1,000 exhibitors and 33,000 trade visitors attended analytica 2008. The 2010 show promises to be the most international analytica to date - there has been a 13% increase in international exhibitors so far. More information at
 www.analytica.de/en
|
Regis Technologies (Morton Grove, IL), a provider of current good manufacturing practice and non-good manufacturing practice synthesis and separations services for active pharmaceutical ingredients and intermediates, received FDA approval to manufacture 4-Aminopyridine, the active ingredient in Ampyra. FDA has approved Ampryra as a treatment to improve walking in patients with multiple sclerosis.
Roche (Basel) announced that results from the first five Phase III studies confirm Roche’s weekly taspoglutide has a positive effect on reducing blood glucose compared with other diabetes treatment options. Roche’s taspoglutide is the first weekly human GLP-1 analogue in late-stage development.
sanofi-aventis (Paris) completed its tender offer for all outstanding shares of common stock of Chattem (Chattanooga TN), which will become a wholly owned subsidiary of sanofi-aventis. The company hopes the transaction will strengthen its presence in the US healthcare market.
Generic-drug company Teva Pharmaceutical Industries (Petach Tikva, Israel) settled a patent dispute with Novartis (Basel) over a herpes treatment. In 2007, Teva launched a generic version of the Novartis’ drug famvir. Under the terms of the settlement, Teva will make a one-time payment to Novartis and provide royalties from US sales.
Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com
|
|
Advertisement:
 Vetter Development Service Chicago
Peter Soelkner
Managing Director, Vetter Pharma International GmbH
Listen to this podcast recorded live from the show floor of AAPS 2009. Clinical development is key for new drugs. In order to minimize risks and take advantage of opportunities, you need comprehensive know-how and years of experience. Vetter, as a specialist in the aseptic filling of injection systems, will provide with its new facility the manufacturing of preclinical, Phase I and Phase II clinical batches in Chicago. We invite you to find out more about Vetter Development Services USA Inc.
|
|
Merck & Co. (Whitehouse Station, NJ) appointed Bridgette P. Heller executive vice-president and president, consumer healthcare. Heller will report to Richard T. Clark, Merck’s chairman, president and chief executive officer.
NextPharma Technologies (Surrey, UK) appointed Ronald Collins interim general manager and Alan Sanders director of finance of its San Diego, California facility. Bruce Johnson was named director of operations; and Mary Richardson was named director of quality.
|
|
 |
|
Implications and Opportunities of Applying QbD Principles to Analytical
Measurements |
|
| By Mark Schweitzer, Matthias Pohl, Melissa Hanna-Brown, Phil Nethercote,
Phil Borman, Gordon Hansen, Kevin Smith, and Jaqueline Larew
| |
The authors present two concepts to improve robustness and facilitate continuous improvement in analytical methods.
Coming Soon: PharmTech's March issue features a preview of the Interphex 2010
conference and exhibition.
|
|
|
|
|
|
|
|
FDA Spending
FDA increased its budget by 19% between FY 2009 and FY 2010, and has asked
for another 23% increase for FY 2011. Rate FDA's request.
|
View the poll archive. |
|
|
|
